Ro: Program features compared Both Noom and Ro provide access to GLP-1 medications for eligible people, but the programs differ in structure, guidance, and ongoing support
a 5-on/2-off weekly variant builds in a pause for those studying receptor-sensitivity preservation
Expert Opinions and Guidelines Professional societies like the American Diabetes Association (ADA) now recommend GLP-1 and dual agonist therapies as frontline options for patients with type 2 diabetes, particularly those with obesity or cardiovascular risk factors
Larazotide (intestinal health) Article: Larazotide: potential for intestinal health Larazotide is a synthetic peptide that shows promise for strengthening intestinal tight junctions to prevent leaky gut syndrome, reducing passage of toxins, bacteria, and undigested food into the bloodstream that triggers inflammation and autoimmune responses
Start tracking before you begin tirzepatide, if possible